YOLFTbeta
CeriBell, Inc

CeriBell, Inc

CBLL · NASDAQ · Healthcare / Medical Devices

26.14USD-0.21 (-0.80%)

Price History

Full chart

Market Stats

Previous Close26.35
Open26.20
Day Range25.86 – 26.42
52-Week Range10.85 – 25.63
Volume267.63K
Market Cap909.18M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.76
Dividend Yield0.00%
50-Day Avg21.87
200-Day Avg20.27

About

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Xingjuan Chao Ph.D.
  • Employees327
  • Headquarters360 North Pastoria Avenue, Sunnyvale, CA, United States, 94085, USA
  • Websitehttps://www.ceribell.com

Leadership

  • Dr. Xingjuan Chao Ph.D.Co-Founder, President, CEO & Director · b. 1981
  • Dr. Josef Parvizi M.D., Ph.D.Co-Founder, Chief Medical Advisor & Director · b. 1969
  • Mr. Scott BlumbergChief Financial Officer
  • Dr. Raymond Woo Ph.D.Chief Technology Officer · b. 1983
  • Ms. Louisa Daniels J.D., M.B.A.General Counsel · b. 1958
  • Mr. Brian P. PriceSenior Vice President of Marketing
  • Ms. Kim McKeonVP of People & Culture
  • Ms. Baharan Kamousi Ph.D.Senior Vice President of Data Science
  • Mr. Joseph Sean ManniChief Revenue Officer · b. 1974
  • Mr. David FoehrSenior Vice President of Finance

Financials

Income Statement

Currency: USD2022-12-312023-12-312024-12-312025-12-31
Total Revenue25.92M45.23M65.44M89.06M
Growth (%)-+74.47%+44.71%+36.09%
Cost of Revenue4.43M7.06M8.69M10.79M
Gross Profit21.49M38.16M56.75M78.27M
Gross Margin82.91%84.38%86.72%87.89%
Operating Expense57.51M68.20M96.46M136.68M
Operating Income-36.02M-30.04M-39.71M-58.40M
Operating Margin-138.96%-66.43%-60.68%-65.57%
EBITDA-35.06M-26.51M-37.32M-50.18M
EBITDA Margin-135.26%-58.61%-57.03%-56.34%
Net Income-37.16M-29.46M-40.45M-53.41M
Net Income Margin-143.37%-65.15%-61.82%-59.97%
R&D7.24M8.99M13.56M19.14M
R&D as % of Total Revenue27.94%19.89%20.72%21.49%
Interest Expense1.60M2.10M1.99M1.89M
Interest Expense % of Total Revenue6.18%4.64%3.04%2.12%

Balance Sheet

Currency: USD2022-12-312023-12-312024-12-312025-12-31
Total Assets86.46M58.92M225.41M195.80M
Total Liabilities172.86M171.17M34.25M40.47M
Total Equity-86.40M-112.25M191.16M155.34M
Cash68.23M34.49M194.37M40.48M
Total Debt18.22M14.20M21.96M22.28M
Net Debt-50.02M-20.29M-172.41M-18.20M

Cash Flow

Currency: USD2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-32.00M-29.16M-35.04M-40.81M
Investing Cash Flow-1.40M-1.76M-1.60M-118.14M
Financing Cash Flow49.80M-2.82M196.52M5.05M
Capital Expenditure516.00K983.00K1.34M767.00K
Free Cash Flow-32.52M-30.14M-36.38M-41.58M
FCF to OCF101.61%103.37%103.82%101.88%

Earnings

Report DateAug 28, 2024Nov 12, 2024Feb 25, 2025May 8, 2025Aug 5, 2025Nov 4, 2025Mar 3, 2026May 11, 2026Aug 10, 2026Nov 3, 2026
EPS Estimate0.00-0.87-0.31-0.46-0.40-0.41-0.41-0.39-0.45-0.50
EPS Actual-0.37-1.85-0.40-0.36-0.38-0.37-0.36-0.38-0.51-
Surprise--112.64%-27.47%21.74%5.00%9.76%12.20%2.56%-13.33%-
Timing-After-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap909.18M
Enterprise Value799.18M
Trailing P/E0.00
Forward P/E0.00
Price / Sales8.92
Price / Book7.07
EPS-1.76
Book Value3.36
Revenue (TTM)101.96M
Gross Profit (TTM)90.64M
EBITDA-68.80M
Profit Margin-64.73%
Operating Margin-71.11%
Return on Equity-43.93%
Return on Assets-23.38%
Shares Outstanding38.38M
Shares Float26.55M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 5 analystsTarget 28.00
  • Strong Buy
    4
  • Buy
    1

Ownership Breakdown

Institutions
87.75%
Insiders
11.84%
Retail / Other
0.41%

Top Institutional Holders

  • FMR Inc
    4.85M12.64%
  • TPG GP A, LLC
    3.97M10.34%
  • Red Tree Management, LLC
    2.21M5.75%
  • BlackRock Inc
    1.81M4.72%
  • Bank of New York Mellon Corp
    1.16M3.02%
  • Vanguard Capital Management, LLC
    1.14M2.96%
  • KCM Capital Inc
    1.13M2.93%
  • Federated Hermes Inc
    939.60K2.45%
  • Adage Capital Partners Gp LLC
    900.00K2.35%
  • Franklin Templeton Inc
    809.51K2.11%
  • TimesSquare Capital Management, LLC
    780.55K2.03%
  • Millennium Management LLC
    727.23K1.89%

Top Fund Holders

  • Fidelity Small Cap Growth
    1.64M4.27%
  • Fidelity Stock Selector Small Cap
    1.00M2.61%
  • Federated Hermes Kaufmann Small Cap A
    939.25K2.45%
  • Vanguard MStar Total Stk Mkt Idx Invest
    850.44K2.22%
  • Fidelity Small Cap Growth K6
    830.54K2.16%
  • Franklin Small Cap Growth Adv
    750.22K1.95%
  • Fidelity Series Small Cap Opps
    737.30K1.92%
  • iShares Russell 2000 ETF
    703.96K1.83%